Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000104

Chairperson & CEO sold 9,500 shares at an average $530.57 ($5,040,380)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-22 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-22 Sale : show line 2 in the form 10b5-1 −120 $524.27 $62,912 333,823 I
2026-07-22 Sale : show line 3 in the form 10b5-1 −485 $526.04 $255,131 333,338 I
2026-07-22 Sale : show line 4 in the form 10b5-1 −2,610 $526.84 $1,375,058 330,728 I
2026-07-22 Sale : show line 5 in the form 10b5-1 −1,211 $527.82 $639,189 329,517 I
2026-07-22 Sale : show line 6 in the form 10b5-1 −874 $528.91 $462,265 328,643 I
2026-07-22 Sale : show line 7 in the form 10b5-1 −760 $529.80 $402,645 327,883 I
2026-07-22 Sale : show line 8 in the form 10b5-1 −400 $531.22 $212,490 327,483 I
Open-market sales · 9,500 sh · avg $530.57 · $5,040,380

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-22 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −9,500 293,910 I
Loading xslF345X06/primarydocument.xml…